Kura Oncology, Inc.
Methods of treating cancer with farnesyltransferase inhibitors
Last updated:
Abstract:
The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating cancer, for example, peripheral T-cell lymphoma ("PTCL"), with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on gene expression characteristics.
Status:
Grant
Type:
Utility
Filling date:
14 Aug 2019
Issue date:
20 Apr 2021